Aleksandra Kropinska, Aleksandra Ledwon, Ewa Paliczka Cieslik, Tomasz Olczyk, Aleksandra Blewaska, Marcela Krzempek, Agata Wilk, Alexander Cortez, Agnieszka Czarniecka, Barbara Jarzab, Daria Handkiewicz Junak
{"title":"Changing Clinical Presentation of Pediatric Differentiated Thyroid Cancer in Poland: A Retrospective Cohort Study Spanning 45 Years.","authors":"Aleksandra Kropinska, Aleksandra Ledwon, Ewa Paliczka Cieslik, Tomasz Olczyk, Aleksandra Blewaska, Marcela Krzempek, Agata Wilk, Alexander Cortez, Agnieszka Czarniecka, Barbara Jarzab, Daria Handkiewicz Junak","doi":"10.1089/thy.2024.0109","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> Differentiated thyroid carcinoma (DTC) in children is uncommon; clinical presentation over recent decades is incompletely characterized. <b><i>Methods:</i></b> This retrospective cohort study analyzed demographic and disease characteristics of consecutive juveniles with DTC treated from 1970 to 2015 at Poland's largest pediatric DTC referral center, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, who had available records. Sex, age, histopathological characteristics, and DTC stage were documented. We aimed to identify changes in these variables over time and independent risk factors for lymph node or distant metastases. Trends in these variables were assessed using the Cochran-Armitage test and Spearman correlation. Multivariable logistic regression was performed to identify risk factors associated with lymph node or distant metastases. <b><i>Results:</i></b> 475 of 479 patients (99.2%) were included in the analysis; roughly half were age ≥15 years, 10%, <10 years. Papillary thyroid carcinoma (PTC) represented 88% of cases and follicular thyroid carcinoma (FTC) 11%. Tumors ≤2 cm constituted 56% of cases with relevant data; those >4 cm accounted for 12%. Multifocality was observed in 37% and extrathyroidal invasion in 22%. Lymph node metastases were noted in 59% and distant metastases in 16%. Over the observation period, significant trends among new cases included: increased proportion of adolescents >15 years; increased frequency of tumors ≤2 cm, decreased multifocality rates, and increased proportion of PTC versus FTC. Extrathyroidal invasion rates remained appreciable throughout, ranging from 17 to 28% during the 5-year study subperiods after 1990. Lymph node metastases significantly increased in frequency in the central neck, remaining consistently common in lateral sites; presence of distant metastases significantly decreased. In multivariable analysis, multifocality, extrathyroidal invasion, and tumor size were independently associated with lateral lymph node metastases and multifocality, larger tumor size, and N1b metastases with distant spread. <b><i>Conclusions:</i></b> Our observations of a rising proportion of diagnoses in adolescence, reductions in primary tumor size, and decreased frequency of multifocality and distant metastases may reflect increased detection of patients with less aggressive DTC at earlier disease stages. Nonetheless, we found persistently substantial rates of locoregionally advanced disease features (multifocality, extrathyroidal invasion, and lymph node metastases), which multivariable analyses suggested have significant associations with lateral lymph node and/or distant metastases.</p>","PeriodicalId":23016,"journal":{"name":"Thyroid","volume":" ","pages":"1234-1245"},"PeriodicalIF":5.8000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thyroid","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/thy.2024.0109","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/25 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Differentiated thyroid carcinoma (DTC) in children is uncommon; clinical presentation over recent decades is incompletely characterized. Methods: This retrospective cohort study analyzed demographic and disease characteristics of consecutive juveniles with DTC treated from 1970 to 2015 at Poland's largest pediatric DTC referral center, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, who had available records. Sex, age, histopathological characteristics, and DTC stage were documented. We aimed to identify changes in these variables over time and independent risk factors for lymph node or distant metastases. Trends in these variables were assessed using the Cochran-Armitage test and Spearman correlation. Multivariable logistic regression was performed to identify risk factors associated with lymph node or distant metastases. Results: 475 of 479 patients (99.2%) were included in the analysis; roughly half were age ≥15 years, 10%, <10 years. Papillary thyroid carcinoma (PTC) represented 88% of cases and follicular thyroid carcinoma (FTC) 11%. Tumors ≤2 cm constituted 56% of cases with relevant data; those >4 cm accounted for 12%. Multifocality was observed in 37% and extrathyroidal invasion in 22%. Lymph node metastases were noted in 59% and distant metastases in 16%. Over the observation period, significant trends among new cases included: increased proportion of adolescents >15 years; increased frequency of tumors ≤2 cm, decreased multifocality rates, and increased proportion of PTC versus FTC. Extrathyroidal invasion rates remained appreciable throughout, ranging from 17 to 28% during the 5-year study subperiods after 1990. Lymph node metastases significantly increased in frequency in the central neck, remaining consistently common in lateral sites; presence of distant metastases significantly decreased. In multivariable analysis, multifocality, extrathyroidal invasion, and tumor size were independently associated with lateral lymph node metastases and multifocality, larger tumor size, and N1b metastases with distant spread. Conclusions: Our observations of a rising proportion of diagnoses in adolescence, reductions in primary tumor size, and decreased frequency of multifocality and distant metastases may reflect increased detection of patients with less aggressive DTC at earlier disease stages. Nonetheless, we found persistently substantial rates of locoregionally advanced disease features (multifocality, extrathyroidal invasion, and lymph node metastases), which multivariable analyses suggested have significant associations with lateral lymph node and/or distant metastases.
背景:儿童分化型甲状腺癌(DTC)并不常见;近几十年来的临床表现特征尚不完整。研究方法这项回顾性队列研究分析了波兰最大的儿童分化型甲状腺癌转诊中心--格利维策玛丽亚-斯克洛多夫斯卡-居里国家肿瘤研究所(Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice)--在1970年至2015年期间接受治疗的连续青少年分化型甲状腺癌患者的人口统计学和疾病特征。性别、年龄、组织病理学特征和 DTC 分期均有记录。我们旨在确定这些变量随时间的变化以及淋巴结或远处转移的独立风险因素。我们使用 Cochran-Armitage 检验和 Spearman 相关性评估了这些变量的变化趋势。进行了多变量逻辑回归,以确定与淋巴结或远处转移相关的风险因素。结果479例患者中有475例(99.2%)被纳入分析;年龄≥15岁的患者约占一半,占10%,4厘米的患者占12%。多灶性占37%,甲状腺外侵犯占22%。淋巴结转移占59%,远处转移占16%。在观察期内,新病例的明显趋势包括:年龄大于15岁的青少年比例增加;肿瘤≤2厘米的频率增加;多发率降低;PTC与FTC的比例增加。甲状腺外侵犯率在1990年后的5年次研究期间始终保持在17%到28%之间。颈部中央淋巴结转移的发生率明显增加,而侧面淋巴结转移则一直很常见;远处转移的发生率明显下降。在多变量分析中,多灶性、甲状腺外侵犯和肿瘤大小与侧方淋巴结转移和多灶性、较大肿瘤大小以及N1b远处转移有独立关联。结论:我们观察到的青少年期诊断比例上升、原发肿瘤大小减小、多发性和远处转移频率降低的现象,可能反映了在疾病早期阶段发现侵袭性较低的 DTC 患者的情况有所增加。然而,我们发现局部区域晚期疾病特征(多发性、甲状腺外侵犯和淋巴结转移)的发生率一直很高,多变量分析表明这些特征与侧淋巴结和/或远处转移有显著的关联。
期刊介绍:
This authoritative journal program, including the monthly flagship journal Thyroid, Clinical Thyroidology® (monthly), and VideoEndocrinology™ (quarterly), delivers in-depth coverage on topics from clinical application and primary care, to the latest advances in diagnostic imaging and surgical techniques and technologies, designed to optimize patient care and outcomes.
Thyroid is the leading, peer-reviewed resource for original articles, patient-focused reports, and translational research on thyroid cancer and all thyroid related diseases. The Journal delivers the latest findings on topics from primary care to clinical application, and is the exclusive source for the authoritative and updated American Thyroid Association (ATA) Guidelines for Managing Thyroid Disease.